BSE grants in-principle approval for issue of 38,71,854 equity shares on preferential basis

Arvaya Healthcare Ltd says it has received in-principle approval from BSE for issuing 38,71,854 equity shares on a preferential basis.

Mon 12 Oct 2026

Shares to be issued

38,71,854 equity shares on a preferential basis

Issue price

Rs. 40/- per equity share

Face value

Rs. 10/- each

Arvaya Healthcare Ltd has informed the exchanges that BSE has granted its in-principle approval for the issue of 38,71,854 equity shares on a preferential basis.

What the company has intimated

• The approval was received from Bombay Stock Exchange Limited through a letter dated October 12, 2026.
• The shares carry a face value of Rs. 10/- each and are to be issued at an issue price of Rs. 40/- per equity share.
• The shares are to be issued on a preferential basis to non-promoters, pursuant to a share swap.

What in-principle approval means

It is the exchange's go-ahead for the proposed issue. The BSE letter states that this in-principle approval should not be construed as approval for the listing of the securities, and that the company is required to comply separately with the requirements for listing. The exchange has also said it may withdraw this in-principle approval at any stage if the information submitted to it is found incomplete, incorrect, misleading or false, or if it contravenes rules, bye-laws and regulations.

What BSE has asked the company to do

• Obtain an undertaking from the proposed allottees confirming that they will not carry out intra-day trading in the company's scrip or sell the scrip till the allotment date.
• Verify that this is complied with, since the responsibility and onus lies solely on the issuer company.
• Make a listing application, with applicable fees, within twenty days from the date of allotment, along with documents specified by the stock exchange. Non-compliance with this requirement attracts a fine.
• Comply with post-issue listing formalities and obtain such statutory and other approvals as may be required.

The approval letter also notes that non-compliances, if observed by the exchanges after the undertaking and verification by the issuer company, may impact the listing of such shares. Separately, it states that on allotment of convertible securities there would be an automatic release of the excess lock-in period of pre-preferential holding of allottees by the depositaries.

Points for an investor to keep in view

• This is a step in the process of raising shares, not the allotment itself. The issue proceeds only after the conditions attached to the approval are met and the shares are allotted.
• A preferential issue adds to the number of equity shares in issue, so the shareholding of existing investors as a percentage of the total can change once the allotment happens.
• The price of Rs. 40/- per equity share and the face value of Rs. 10/- per share are the two figures stated for the proposed issue.

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.